Evidence map›Paper›PMID 41945372›Full record

ArticleClinical nuclear medicine2026

Incidental Detection of a CAIX-avid Breast Invasive Ductal Carcinoma on 68 Ga-NY104 PET/CT During Evaluation of a Suspected Renal Mass.

Xinchun Yan, Yichen Xie, Meixi Liu, Wenjia Zhu, Li Huo

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xinchun YanDepartment of Nuclear Medicine, Beijing Key Laboratory of Targeted Radiopharmaceutical Development and Translational Nuclear Medicine, State Key Laboratory of Complex, Severe, and Rare Diseases, Center for Rare Diseases Research, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yichen Xie
Meixi Liu
Wenjia Zhu
Li Huo

Funding

Peking Union Medical College Hospital Talent Cultivation Program (Category D) UHB12582
6 · The paper itself

Abstract

68 Ga-NY104 is a novel tracer targeting carbonic anhydrase IX (CAIX) with promising diagnostic efficacy for clear cell renal cell cancer. We present a 55-year-old woman with a suspected left renal mass who underwent 68 Ga-NY104, showing no significant uptake in the renal mass but incidentally revealing an intense uptake nodule in the left breast. Subsequent 18 F-FDG PET/CT revealed mild renal mass and intense breast nodule uptake. Postoperative pathology confirmed the renal mass as benign angiomyolipoma and the breast nodule as invasive ductal carcinoma. This case highlights the inclusion of primary breast cancer in the differential diagnosis of extra-renal CAIX-avid lesions.

Indexed as

Breast NeoplasmsCarbonic Anhydrase IXCarcinoma, Ductal, BreastIncidental FindingsKidney NeoplasmsPositron Emission Tomography Computed TomographyAntigens, NeoplasmFemaleGallium RadioisotopesHumansMiddle AgedAntigens, NeoplasmCA9 protein, humanCarbonic Anhydrase IXGallium Radioisotopescarbonic anhydrase IXinvasive ductal carcinoma

Identifiers

PMID41945372
PMCPMC13132082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.